The development of Jack Jumper ant venom immunotherapy: our 25 years' experience.

Troy WanandyThanh-Thao A LeWun Y LauMichael D WieseRobert J HeddleSimon G A Brown

Published in: Internal medicine journal (2023)

Jack Jumper ant venom allergy is a uniquely Australian medical issue. The stinging ant is a leading cause of insect venom allergy in south-eastern Australia. An effective venom immunotherapy-based treatment was successfully developed by the Tasmanian Jack Jumper Allergy Research group. This paper provides a synopsis of our 25 years' research journey in developing this evidence-based treatment modality.

Keyphrases

healthcare
atopic dermatitis
south africa
zika virus
smoking cessation
aedes aegypti